Rx onlyMulti-targeted tyrosine kinase inhibitor
Sunitinib
- Strength
- 12.5 mg Capsules
- Pack
- 30 capsules
Indicated in
Pancreatic Neuroendocrine Tumours
Targeted therapy used in progressive, well-differentiated pancreatic neuroendocrine tumours.
1 medicine available · Prescription required
Available medicines (1)
Rx onlyWhich medicine is suitable depends on the stage of the cancer, previous treatment and your overall health. Your oncologist will decide the right therapy, dose and schedule.
Patient Resources
Medicine guides & treatment information
Clear, evidence-based articles on our medicines, the cancers they treat and how to manage treatment at home.
Medicine Guides· 7 min read
Sunitinib: Treatment for Kidney Cancer, GIST and Pancreatic NETs
What patients should know about Sunitinib — the cancers it is approved for, typical treatment schedules, monitoring and side effects.
Managing Treatment· 7 min read
Managing Common Side Effects of Oral Targeted Cancer Therapy
Practical guidance for patients and caregivers on hand-foot skin reaction, high blood pressure, diarrhoea and fatigue during treatment with tyrosine kinase inhibitors.
Other cancer types
Patients & Caregivers
Need help finding a medicine?
Share your prescription with our team and we'll confirm availability, pack size and delivery for you.
Hospitals, Clinics & Pharmacies
Bulk & institutional supply
Dependable supply of oncology medicines for institutions, with documentation available on request.
Partner with usMedical disclaimer: Information on this website is for general reference only and is not a substitute for professional medical advice. Oncology medicines must be used only under the supervision of a qualified oncologist and are supplied against a valid prescription.